Literature DB >> 18245237

Development of inducible systems to engineer conditional mutants of essential genes of Helicobacter pylori.

Ivo G Boneca1, Chantal Ecobichon, Catherine Chaput, Aurélie Mathieu, Stéphanie Guadagnini, Marie-Christine Prévost, Frédéric Colland, Agnès Labigne, Hilde de Reuse.   

Abstract

The Escherichia coli-Helicobacter pylori shuttle vector pHeL2 was modified to introduce the inducible LacI(q)-pTac system of E. coli, in which the promoters were engineered to be under the control of H. pylori RNA polymerase. The amiE gene promoter of H. pylori was taken to constitutively express the LacI(q) repressor. Expression of the reporter gene lacZ was driven by either pTac (pILL2150) or a modified version of the ureI gene promoter in which one or two LacI-binding sites and/or mutated nucleotides between the ribosomal binding site and the ATG start codon (pILL2153 and pILL2157) were introduced. Promoter activity was evaluated by measuring beta-galactosidase activity. pILL2150 is a tightly regulated expression system suitable for the analysis of genes with low-level expression, while pILL2157 is well adapted for the controlled expression of genes encoding recombinant proteins in H. pylori. To exemplify the usefulness of these tools, we constructed conditional mutants of the putative essential pbp1 and ftsI genes encoding penicillin-binding proteins 1 and 3 of H. pylori, respectively. Both genes were cloned into pILL2150 and introduced in the parental H. pylori strain N6. The chromosomally harbored pbp1 and ftsI genes were then inactivated by replacing them with a nonpolar kanamycin cassette. Inactivation was strictly dependent upon addition of isopropyl-beta-d-thiogalactopyranoside. Hence, we were able to construct the first conditional mutants of H. pylori. Finally, we demonstrated that following in vitro methylation of the recombinant plasmids, these could be introduced into a large variety of H. pylori isolates with different genetic backgrounds.

Entities:  

Mesh:

Year:  2008        PMID: 18245237      PMCID: PMC2292604          DOI: 10.1128/AEM.01348-07

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN: 0099-2240            Impact factor:   4.792


  40 in total

1.  Proteome analysis of secreted proteins of the gastric pathogen Helicobacter pylori.

Authors:  Dirk Bumann; Sevil Aksu; Meike Wendland; Katharina Janek; Uschi Zimny-Arndt; Nicolas Sabarth; Thomas F Meyer; Peter R Jungblut
Journal:  Infect Immun       Date:  2002-07       Impact factor: 3.441

2.  Systematic identification of selective essential genes in Helicobacter pylori by genome prioritization and allelic replacement mutagenesis.

Authors:  A F Chalker; H W Minehart; N J Hughes; K K Koretke; M A Lonetto; K K Brinkman; P V Warren; A Lupas; M J Stanhope; J R Brown; P S Hoffman
Journal:  J Bacteriol       Date:  2001-02       Impact factor: 3.490

3.  Identification of environmental stress-regulated genes in Helicobacter pylori by a lacZ reporter gene fusion system.

Authors:  N de Vries; E J Kuipers; N E Kramer; A H van Vliet; J J Bijlsma; M Kist; S Bereswill; C M Vandenbroucke-Grauls; J G Kusters
Journal:  Helicobacter       Date:  2001-12       Impact factor: 5.753

4.  Helicobacter pylori strain-specific differences in genetic content, identified by microarray, influence host inflammatory responses.

Authors:  D A Israel; N Salama; C N Arnold; S F Moss; T Ando; H P Wirth; K T Tham; M Camorlinga; M J Blaser; S Falkow; R M Peek
Journal:  J Clin Invest       Date:  2001-03       Impact factor: 14.808

5.  Competition of various beta-lactam antibiotics for the major penicillin-binding proteins of Helicobacter pylori: antibacterial activity and effects on bacterial morphology.

Authors:  C R DeLoney; N L Schiller
Journal:  Antimicrob Agents Chemother       Date:  1999-11       Impact factor: 5.191

6.  Identification of nonessential Helicobacter pylori genes using random mutagenesis and loop amplification.

Authors:  P J Jenks; C Chevalier; C Ecobichon; A Labigne
Journal:  Res Microbiol       Date:  2001-10       Impact factor: 3.992

7.  The protein-protein interaction map of Helicobacter pylori.

Authors:  J C Rain; L Selig; H De Reuse; V Battaglia; C Reverdy; S Simon; G Lenzen; F Petel; J Wojcik; V Schächter; Y Chemama; A Labigne; P Legrain
Journal:  Nature       Date:  2001-01-11       Impact factor: 49.962

8.  Overcoming the restriction barrier to plasmid transformation of Helicobacter pylori.

Authors:  J P Donahue; D A Israel; R M Peek; M J Blaser; G G Miller
Journal:  Mol Microbiol       Date:  2000-09       Impact factor: 3.501

9.  Predictive factors for regression of gastric MALT lymphoma after anti-Helicobacter pylori treatment.

Authors:  A Ruskoné-Fourmestraux; A Lavergne; P H Aegerter; F Megraud; L Palazzo; A de Mascarel; T Molina; J L Rambaud
Journal:  Gut       Date:  2001-03       Impact factor: 23.059

10.  HobA--a novel protein involved in initiation of chromosomal replication in Helicobacter pylori.

Authors:  Anna Zawilak-Pawlik; Agnieszka Kois; Kerstin Stingl; Ivo G Boneca; Paulina Skrobuk; Jakimowicz Piotr; Rudi Lurz; Jolanta Zakrzewska-Czerwińska; Agnés Labigne
Journal:  Mol Microbiol       Date:  2007-07-21       Impact factor: 3.501

View more
  37 in total

1.  A convenient and robust in vivo reporter system to monitor gene expression in the human pathogen Helicobacter pylori.

Authors:  Andrea Vannini; Francesca Agriesti; Flaviana Mosca; Davide Roncarati; Vincenzo Scarlato; Alberto Danielli
Journal:  Appl Environ Microbiol       Date:  2012-07-06       Impact factor: 4.792

2.  Employing site-specific recombination for conditional genetic analysis in Sinorhizobium meliloti.

Authors:  Clarice L Harrison; Matthew B Crook; Gledi Peco; Sharon R Long; Joel S Griffitts
Journal:  Appl Environ Microbiol       Date:  2011-04-22       Impact factor: 4.792

3.  Study of the functionality of the Helicobacter pylori trans-translation components SmpB and SsrA in an heterologous system.

Authors:  Marie Thibonnier; Sylvie Aubert; Chantal Ecobichon; Hilde De Reuse
Journal:  BMC Microbiol       Date:  2010-03-26       Impact factor: 3.605

4.  Control of gene expression in Helicobacter pylori using the Tet repressor.

Authors:  Mark S McClain; Stacy S Duncan; Jennifer A Gaddy; Timothy L Cover
Journal:  J Microbiol Methods       Date:  2013-10-08       Impact factor: 2.363

5.  Identification of the RNA Pyrophosphohydrolase RppH of Helicobacter pylori and Global Analysis of Its RNA Targets.

Authors:  Thorsten Bischler; Ping-Kun Hsieh; Marcus Resch; Quansheng Liu; Hock Siew Tan; Patricia L Foley; Anika Hartleib; Cynthia M Sharma; Joel G Belasco
Journal:  J Biol Chem       Date:  2016-12-14       Impact factor: 5.157

6.  Genome sequence of Helicobacter pylori hpEurope strain N6.

Authors:  Wiebke Behrens; Tobias Bönig; Sebastian Suerbaum; Christine Josenhans
Journal:  J Bacteriol       Date:  2012-07       Impact factor: 3.490

Review 7.  Cell morphology as a virulence determinant: lessons from Helicobacter pylori.

Authors:  Nina R Salama
Journal:  Curr Opin Microbiol       Date:  2020-01-31       Impact factor: 7.934

8.  A peptide of a type I toxin-antitoxin system induces Helicobacter pylori morphological transformation from spiral shape to coccoids.

Authors:  Lamya El Mortaji; Alejandro Tejada-Arranz; Aline Rifflet; Ivo G Boneca; Gérard Pehau-Arnaudet; J Pablo Radicella; Stéphanie Marsin; Hilde De Reuse
Journal:  Proc Natl Acad Sci U S A       Date:  2020-11-23       Impact factor: 11.205

9.  Development of a tetracycline-inducible gene expression system for the study of Helicobacter pylori pathogenesis.

Authors:  Aleksandra W Debowski; Phebe Verbrugghe; Miriam Sehnal; Barry James Marshall; Mohammed Benghezal
Journal:  Appl Environ Microbiol       Date:  2013-09-20       Impact factor: 4.792

10.  RNase J depletion leads to massive changes in mRNA abundance in Helicobacter pylori.

Authors:  Yulia Redko; Eloïse Galtier; Hélène Arnion; Fabien Darfeuille; Odile Sismeiro; Jean-Yves Coppée; Claudine Médigue; Marion Weiman; Stéphane Cruveiller; Hilde De Reuse
Journal:  RNA Biol       Date:  2016       Impact factor: 4.652

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.